Detalhe da pesquisa
1.
Immunogenicity and safety of RAZI recombinant spike protein vaccine (RCP) as a booster dose after priming with BBIBP-CorV: a parallel two groups, randomized, double blind trial.
BMC Med
; 22(1): 78, 2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38378570
2.
Mortality and re-fracture rates in low trauma hip fracture.
BMC Geriatr
; 24(1): 381, 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38684943
3.
Safety and efficacy of the FAKHRAVAC compared with BBIBP-Corv2 against SARS-CoV-2 in adults: a non-inferiority multi-center trial.
Virol J
; 20(1): 154, 2023 07 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37464440
4.
Phase II randomized, double blind, placebo controlled, clinical trial of safety and immunogenicity of an inactivated SARS-CoV-2 vaccine FAKHRAVAC in adults aged 18-70 years.
BMC Infect Dis
; 23(1): 118, 2023 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36829111
5.
Geographic distribution and time trends of water-pipe use among Iranian youth and teenage students: A meta-analysis and systematic review.
J Ethn Subst Abuse
; 22(2): 285-315, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-34486927
6.
The efficacy of corticosteroids therapy in patients with moderate to severe SARS-CoV-2 infection: a multicenter, randomized, open-label trial.
Respir Res
; 22(1): 245, 2021 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34526033
7.
Cardio-metabolic and socio-demographic risk factors associated with dependency in basic and instrumental activities of daily living among older Iranian adults: Bushehr elderly health program.
BMC Geriatr
; 21(1): 172, 2021 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33750321
8.
Safety and efficacy of RCP recombinant spike protein covid-19 vaccine compared to Sinopharm BBIBP: A phase III, non-inferiority trial.
Heliyon
; 10(5): e27370, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38463808
9.
Immunogenicity and Safety of a Combined Intramuscular/Intranasal Recombinant Spike Protein COVID-19 Vaccine (RCP) in Healthy Adults Aged 18 to 55 Years Old: A Randomized, Double-Blind, Placebo-Controlled, Phase I Trial.
Vaccines (Basel)
; 11(2)2023 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36851334
10.
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine (FAKHRAVAC®) in healthy adults aged 18-55 years: Randomized, double-blind, placebo-controlled, phase I clinical trial.
Vaccine X
; 15: 100401, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37941802
11.
Phase II, Safety and Immunogenicity of RAZI Cov Pars (RCP) SARS Cov-2 Vaccine in Adults Aged 18-70 Years; A Randomized, Double-Blind Clinical Trial.
J Pharm Sci
; 112(12): 3012-3021, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37832918
12.
Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia.
Int Immunopharmacol
; 95: 107522, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33735712